Skip to main navigation Skip to search Skip to main content

Studies from Johns Hopkins University in the Area of Cancer Reported [Trastuzumab and Pertuzumab In Patients With Non-breast/gastroesophageal her2 -amplified Tumors: Results From the Nci-match Ecog-acrin Trial (Eay131) Subprotocol J]

Press/Media

Period29 Apr 2024

Media coverage

1

Media coverage

  • TitleStudies from Johns Hopkins University in the Area of Cancer Reported [Trastuzumab and Pertuzumab In Patients With Non-breast/gastroesophageal her2 -amplified Tumors: Results From the Nci-match Ecog-acrin Trial (Eay131) Subprotocol J]
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date29/04/24
    PersonsRoisin Connolly